Ornithine transcarbamylase (OTC) catalyzes the formation of citrulline from carbamoyl phosphate and l-ornithine in the urea cycle, deleterious mutations in the human OTC gene disrupts the formation and produces clinical hyperammonemia, which can also lead to encephalopathy with subsequent neurological symptoms or even death. This evidence concerns the gene OTC and Hyperammonemia.